arrow
J

Juliana Pereira

University of São Paulo
H指数:25
被引数:2,703

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrated TCRγ Clonality Workflow for Molecular Diagnosis in HTLV-1 Carriers and Adult T-Cell Leukemia/Lymphoma

整合TCRγ克隆性工作流程用于HTLV-1携带者和成人T细胞白血病/淋巴瘤的分子诊断

2026-07-230
OA
Epigenetic dysregulation in mycosis fungoides and sézary syndrome

在蕈样真菌病和塞扎里综合征中的表观遗传失调

2026-05-110
OAAI
Soluble E-Cadherin as a New Prognostic Biomarker Able to Predict Survival in Newly Diagnosed Diffuse Large B-Cell Lymphoma

可溶性E-钙黏蛋白作为能预测新诊断弥漫性大B细胞淋巴瘤患者生存的新预后生物标志物

2026-04-270
OAAI
7-Ketocholesterol Links Sterol Homeostasis to Hedgehog Signaling and Stress–Survival Responses in MSCs from Patients with Acute Myeloid Leukemia

7-Ketocholesterol将急性髓系白血病患者MSCs中的类固醇稳态与Hedgehog信号通路以及应激-存活反应联系起来

2026-03-300
OAAI
UNDERSTANDING B-CELL LYMPHOMA PROGRESSION IN PATIENTS AWAITING AUTOLOGOUS TRANSPLANT IN A RESOURCE-CONSTRAINED SETTING

理解资源受限环境下等待自体移植患者的B细胞淋巴瘤进展

2025-12-180
PRE
Central Nervous System Involvement in Aggressive ATLL: Can We Predict the Risk in a Devastating Complication? Epidemiology and Clinical Features from Latin America. a Collaborative Study from Grupo De Estudio Latino-Americano De Linfoproliferativo (GELL) &T-Cell Brazil Project (TCBP)

侵袭性ATLL的中枢神经系统受累:我们能否预测这一灾难性并发症的风险?流行病学和临床特征来自拉丁美洲。拉丁美洲淋巴增殖性疾病研究组(GELL)与巴西T细胞项目(TCBP)的协作研究。

BLOOD
IF23.1
2024-11-050
PRE
Long-Term Safety and Effectiveness of Rituximab Biosimilar RTXM83: A Retrospective Extension Study in Brazilian Patients with Diffuse Large B-Cell Lymphoma
2024-06-030
OAAI
Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study
2023-10-1610
OAAI
GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms
2022-11-0414
OAAI
Outcomes and Prognostic Factors in a Large Cohort of Hospitalized Cancer Patients With COVID-19
2021-12-0114
OAAI